J. Callaghan

1.3k citations
24 papers · 899 indexed · h-index 15

Impact in

    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Adverse Reactions
  • Biomaterials top 10%
    • Electrospun Nanofibers in Biomedical Applications

Papers in

J. Callaghan

23 papers receiving 879 citations

Peers

J. Callaghan
Comparison fields: 5 of 108
  • Pharmacology 145
  • Pharmacology 154
  • Biomaterials 117
  • Toxicology 25
  • Pathology and Forensic Medicine 105
Replace Cheng Chen with:
Cheng Chen China
Min Dai China
Dan Gheban Romania
Sylvain Poujol France
Ok‐Joo Sul South Korea
C. MacDonald United Kingdom
Jingcheng Wang China
Galina Shapiro Israel
J. Callaghan relative to Cheng Chen China Cheng Chen's profile →
Citations per field
00.5×3.7×
Cheng Chen · 1×
Citations per year

Countries citing papers authored by J. Callaghan

Since Specialization
Citations

This map shows the geographic impact of J. Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Callaghan more than expected).

Fields of papers citing papers by J. Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Callaghan. The network helps show where J. Callaghan may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Callaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Callaghan Line = papers co-authored together J. Callaghan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014163
2 1985146
3 2015116
4 200559
5 201757
6
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
200053
7 199240
8 200538
9 202136
10 201836
11 200833
12 200730
13 199921
14 201618
15 200715
16 19989
17
Hybrid capture as a means of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation.
20019
18 20028
19
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
20146
20 19832

About J. Callaghan

J. Callaghan is a scholar working on Pharmacology, Immunology and Allergy, Surfaces, Coatings and Films, Cardiology and Cardiovascular Medicine and Pharmaceutical Science, having authored 24 papers that have together received 899 indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Orthopaedic implants and arthroplasty (3 papers), Cell Adhesion Molecules Research (2 papers), Electrospun Nanofibers in Biomedical Applications (2 papers), Pharmaceutical studies and practices (2 papers), Viral Infections and Immunology Research (2 papers) and Total Knee Arthroplasty Outcomes (2 papers). The work is most often cited by research in Pharmacology (145 citations), Pharmacology (154 citations), Biomaterials (117 citations), Toxicology (25 citations) and Pathology and Forensic Medicine (105 citations). J. Callaghan has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include John A. Hunt, Teri E. Klein, P C Adams, A R Morley, R. Wayne Campbell, D W Holt, Michelle Whirl‐Carrillo, Allan E. Rettie, M T M Lee and Scott Mintzer. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Biomaterials, Biochemical Society Transactions, Journal of Allergy and Clinical Immunology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026